Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China flag China · Delayed Price · Currency is CNY
5.18
+0.11 (2.17%)
Mar 10, 2026, 3:04 PM CST

Guizhou Bailing Group Pharmaceutical Company Description

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China.

It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey.

Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.

Guizhou Bailing Group Pharmaceutical Co., Ltd.
Country China
Founded 1999
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 6,586
CEO Min Niu

Contact Details

Address:
No. 212, Xihang Road
Anshun, 561000
China
Phone 86 851 3341 5126
Website gzbl.com

Stock Details

Ticker Symbol 002424
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000PY3
SIC Code 2834

Key Executives

Name Position
Wei Jiang Acting Secretary of the Board of Directors and Chairman
Min Niu GM and Director
Hongxing Li Chief Financial Officer
Pei Chen Deputy GM and Director
Yuan Zhen Yuan Executive Vice President
Yong Jiang Director
Zhining Wu Accounting Supervisor